Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases

Published:2020-05 Issue:5 Volume:18 Page:1142-1151.e10
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Verstockt Bram^ORCID,Verstockt Sare^ORCID,Veny Marisol^ORCID,Dehairs Jonas^ORCID,Arnauts Kaline,Van Assche Gert,De Hertogh Gert^ORCID,Vermeire Séverine,Salas Azucena,Ferrante Marc

Funder

Belgium Week of Gastroenterology

Belgian IBD Research and Development group

IBD Patient’s Association Flanders

Flemish association for Gastroenterology

European Crohn’s and Colitis Organization Research Grant

Belgian IBD Research and Development group Research Grant

Advanced European Research Council

Takeda

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. New treatment options for inflammatory bowel diseases;Verstockt;J Gastroenterol,2018

2. New biologics and small molecules in inflammatory bowel disease. An update;Sabino;Therap Adv Gastroenterol,2019

3. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease;West;Nat Med,2017

4. Cell-centred meta-analysis reveals baseline predictors of anti-TNFalpha non-response in biopsy and blood of patients with IBD;Gaujoux;Gut,2019

5. TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?;Verstockt;Gut,2019

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte subsets for predicting inflammatory bowel disease progression and treatment response: a systematic review;Frontiers in Immunology;2024-08-20

2. Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study;2024-07-25

3. Biomarkers for Personalizing IBD Therapy: The Quest Continues;Clinical Gastroenterology and Hepatology;2024-07

4. How Artificial Intelligence Will Transform Clinical Care, Research, and Trials for Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07

5. Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach;International Journal of Molecular Sciences;2024-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3